Please Click on View Investor Video Below
View Investor Video - Windows Movie 
View Investor Video - Mac MP4 
Download Investor presentation - PDF file  |
 |
| |
Minomic International Limited specialises in the development and commercialisation of diagnostic products. The first of two releases is for Prostate Cancer, the most common cancer in Australian men after skin cancer and the second highest cause of male cancer deaths.
Every year, 2,700 men die from Prostate Cancer in Australia. To find out more click here. |
| |
 |
| |
The prostate is a male-only organ located immediately below the bladder and just in front of the bowel. To find out more click here. |
|
 |
| |
Prostate Cancer: The testing of Prostate Cancer in men has experienced exponential growth over recent years and is set to grow significantly, due to better education amongst men and women. Worldwide over 60 million men will have a Prostate Cancer test in 2008. |
| Read More : |
| |
| Diabetes (Type 2): As the most common form of diabetes, Type 2 Diabetes, is known as the 'lifestyle disease' accounts for 90 percent of all people with diabetes. |
| Read More : |
|
 |
| |
PROSTATE CANCER TESTING SET TO INCREASE
Prostate Cancer tests are set to increase dramatically with the aid of a new diagnostic being developed... |
| |
| Read More : |
| |
MINOMIC INTERNATIONAL TO COMMERCIALISE PROSTATE CANCER AND DIABETES (TYPE 2) DIAGNOSTICS
Minomic International Limited has commenced its international marketing... |
| Read More : |
|